
European Journal of Heart Failure: A Leading Publication in Cardiovascular Research
The European Journal of Heart Failure (EJHF) is one of the most respected and influential peer-reviewed medical journals in the field of cardiology. Published by Wiley on behalf of the European Society of Cardiology (ESC), the journal focuses on all aspects of heart failure, from basic research and translational studies to clinical trials and real-world practice. As the official journal of the Heart Failure Association (HFA) of the ESC, the EJHF is a key resource for cardiologists, researchers, clinicians, and healthcare professionals around the globe.
The primary aim of the European Journal of Heart Failure is to advance the understanding and treatment of heart failure. It covers a wide range of topics including:
Epidemiology and prevention
Clinical management and pharmacotherapy
Advanced heart failure therapies (e.g., LVADs, transplantation)
Pathophysiology and molecular biology
Imaging and diagnostics
Guidelines and position statements
By publishing high-quality, evidence-based articles, the journal promotes best practices and encourages innovation in heart failure management and research.
The European Journal of Heart Failure is known for its high impact factor, reflecting the significance and influence of its published content. The journal regularly features:
Original research articles
Systematic reviews and meta-analyses
Editorials and expert commentaries
Clinical trial results
Case reports and real-world data studies
The journal plays a pivotal role in translating scientific discoveries into clinical practice, helping healthcare professionals make informed decisions to improve patient outcomes.
The EJHF has a wide international readership and is indexed in major scientific databases including PubMed, MEDLINE, and Scopus. Its online accessibility and Open Access options ensure that content is available to researchers and clinicians worldwide. The journal’s commitment to scientific integrity and open scientific dialogue makes it a trusted source of information for cardiology professionals.
The journal's editorial board comprises leading cardiologists, researchers, and academics with extensive experience in heart failure and cardiovascular medicine. All submissions undergo a rigorous peer-review process to ensure accuracy, relevance, and scientific validity. This commitment to excellence ensures the journal maintains its reputation as a top-tier publication in the cardiovascular field.
About the European Journal of Heart Failure
The European Journal of Heart Failure (EJHF) is a leading peer-reviewed medical journal dedicated to advancing research and clinical practice in the field of heart failure. Published by the prestigious European Society of Cardiology (ESC) on behalf of the Heart Failure Association (HFA), the journal serves as a critical resource for cardiologists, researchers, and healthcare professionals worldwide.
As one of the most cited journals in cardiovascular medicine, the European Journal of Heart Failure focuses on publishing high-quality original research, review articles, clinical trials, case reports, and editorials that address the pathophysiology, diagnosis, treatment, and prevention of heart failure. With a strong emphasis on translational science and clinical relevance, the journal plays a pivotal role in shaping modern cardiovascular medicine and improving patient care.
With a high impact factor and international readership, the EJHF is recognized for its rigorous peer-review process and commitment to publishing scientifically sound and clinically impactful content. It provides a global platform for cutting-edge research and expert opinion, making it an essential reference for professionals involved in heart failure care and research.
Topics commonly featured include:
Acute and chronic heart failure
Heart failure with preserved ejection fraction (HFpEF)
Cardiomyopathies
Cardiac imaging and biomarkers
Advanced heart failure therapies
Device therapy and transplantation
Heart failure comorbidities and patient management
The journal also plays a key role in disseminating the official guidelines and consensus statements from the Heart Failure Association of the ESC, ensuring that clinicians are equipped with the latest evidence-based practices.
The European Journal of Heart Failure is published monthly and is available both in print and online. It is indexed in major databases including PubMed, MEDLINE, Scopus, and Web of Science, which ensures wide visibility and accessibility to the scientific community.
For researchers and clinicians, the journal provides an invaluable source of the most recent developments in heart failure research, from early-phase mechanistic studies to large-scale clinical trials and meta-analyses.
Reputation & Credibility: Backed by the ESC and HFA, the journal is trusted by experts around the world.
High-Quality Peer Review: Ensures scientific rigor and clinical relevance.
Global Audience: Reach a broad readership of healthcare professionals, academics, and industry experts.
Timely Updates: Stay informed with the latest research, guidelines, and innovations in heart failure care.
Researchers and clinicians are encouraged to submit their original studies and review articles to the European Journal of Heart Failure. With a fast and efficient review process, authors benefit from the journal’s high visibility and strong reputation in the cardiovascular field.
For more information, visit the official journal page at the ESC website or explore the latest issues online to stay current with breakthroughs in heart failure science.
Scope of the European Journal of Heart Failure (EJHF)
The European Journal of Heart Failure (EJHF) is a premier peer-reviewed medical journal that serves as a vital platform for advancing knowledge, research, and clinical practice in the field of heart failure. As the official journal of the Heart Failure Association of the European Society of Cardiology (ESC), the EJHF is dedicated to publishing high-quality articles that significantly contribute to the understanding, diagnosis, treatment, and prevention of heart failure globally.
The scope of the European Journal of Heart Failure encompasses a broad spectrum of topics related to heart failure research and patient care. This includes, but is not limited to:
Pathophysiology of Heart Failure: The journal features studies exploring the mechanisms behind heart failure, including myocardial remodeling, neurohormonal activation, and cellular and molecular biology.
Clinical Research: EJHF publishes original clinical investigations, randomized controlled trials, and real-world evidence studies that influence contemporary clinical guidelines.
Pharmacological and Non-pharmacological Treatments: Articles include the latest developments in drug therapies, device-based treatments, surgical interventions, and lifestyle modifications for managing heart failure.
Advanced Heart Failure and Transplantation: The journal covers research on mechanical circulatory support, cardiac transplantation, and end-stage heart failure management.
Imaging and Diagnostics: Contributions on advancements in echocardiography, cardiac MRI, biomarkers, and diagnostic tools are frequently featured.
Heart Failure with Preserved Ejection Fraction (HFpEF) and Reduced Ejection Fraction (HFrEF): Differentiation and tailored management strategies for these major heart failure subtypes are core topics of interest.
The EJHF is intended for cardiologists, heart failure specialists, internists, researchers, and healthcare professionals involved in cardiovascular medicine. The journal enjoys a wide international readership and a high impact factor, making it a trusted source of the latest advancements in heart failure care.
The European Journal of Heart Failure is pivotal in bridging the gap between scientific discovery and clinical application. By publishing editorials, reviews, case reports, and clinical trial data, the EJHF helps healthcare providers stay current with evidence-based practices and innovations in heart failure management.
Maintaining rigorous peer-review standards and editorial integrity, the EJHF ensures that every publication is scientifically robust and clinically relevant. The journal actively encourages interdisciplinary submissions that integrate cardiology with fields such as nephrology, endocrinology, and geriatrics, reflecting the complex, multisystem nature of heart failure.